CPC
ABCL icon

Cookson Peirce & Co’s AbCellera Biologics ABCL Stock Holding History

Cookson Peirce & Co’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$785K Buy
+100,000
New +$489K 0.03% 226
2024
Q1 		– Sell
-20,000
Closed -$114K – 220
2023
Q4 		$114K Hold
20,000
– – 0.01% 207
2023
Q3 		$92K Buy
+20,000
New +$122K 0.01% 202

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Cookson Peirce & Co's ABCL Position: Q2 2026 in Review

Cookson Peirce & Co opened a new position in AbCellera Biologics (ABCL) in Q2 2026: 100,000 shares worth $785K. The stake represents 0.03% of the portfolio and ranks #226 among its holdings. This is a return to the name: Cookson Peirce & Co previously reported a position in ABCL as recently as Q4 2023.

Cookson Peirce & Co first reported a position in ABCL in Q3 2023 and has held it in 3 quarters since. 151 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • Cookson Peirce & Co held 100,000 shares of AbCellera Biologics worth $785K as of Q2 2026.
  • AbCellera Biologics was a new Cookson Peirce & Co position in Q2 2026.
  • AbCellera Biologics made up 0.03% of Cookson Peirce & Co's portfolio in Q2 2026, its #226 holding.
  • Cookson Peirce & Co first reported a position in AbCellera Biologics in Q3 2023 and has held it in 3 quarters since.
  • 151 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on Cookson Peirce & Co's 13F filing for Q2 2026, filed 23 Jul 2026.